Skip to main content

VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial (2023-24)

Product name
VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial
Sponsor name
Abbvie Pty Ltd
Year Range
2023-24

Help us improve the Therapeutic Goods Administration site